Inventor · disambiguated record
Andrew Griffin
Also filed as: GRIFFIN ANDREW · GRIFFIN ANDREW M · GRIFFIN ANDREW MARK
56 granted patents·61 pending applications·317 citations·filing 1999–2025
98Inventor score
Files withPRAXIS PREC MEDICINES INC40ASTRAZENECA AB27SAGE THERAPEUTICS INC17NEOMED INST8PRETZEL THERAPEUTICS INC8
Top patents by PatentIndex Score
117 records- 0198US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
- 0298US11279700B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Mar 22, 2022·13 cites·20 claims
- 0398US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
- 0498US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
- 0598US11014931B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2020·Granted May 25, 2021·18 cites·18 claims
- 0697US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
- 0796US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
- 0896US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 0995US12180247B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·2 cites·12 claims
- 1095US11773088B2KCNT1 inhibitors and methods of usePRAXIS PREC MEDICINES INC·Filed 2021·Granted Oct 3, 2023·3 cites·19 claims
- 1195US11731978B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2022·Granted Aug 22, 2023·2 cites·4 claims
- 1295US11261188B2Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channelPRAXIS PREC MEDICINES INC·Filed 2017·Granted Mar 1, 2022·11 cites·16 claims
- 1393US11767325B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Sep 26, 2023·3 cites·16 claims
- 1493US11731976B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2021·Granted Aug 22, 2023·2 cites·30 claims
- 1592US11278535B2Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2018·Granted Mar 22, 2022·11 cites·12 claims
- 1690US11396525B2C17, C20, and C21 substituted neuroactive steroids and their methods of useSAGE THERAPEUTICS INC·Filed 2017·Granted Jul 26, 2022·8 cites·15 claims
- 1790US11365186B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2020·Granted Jun 21, 2022·3 cites·10 claims
- 1888US11149056B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·5 cites·11 claims
- 1987US11981657B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 2086US12325711B23-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulatorPRAXIS PREC MEDICINES INC·Filed 2023·Granted Jun 10, 2025·0 cites·32 claims
- 2185US12331070B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Granted Jun 17, 2025·0 cites·4 claims
- 2285US10781231B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 22, 2020·4 cites·20 claims
- 2385US10703740B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Jul 7, 2020·3 cites·13 claims
- 2484US2025388622A1C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2583US11629146B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activityPRAXIS PREC MEDICINES INC·Filed 2017·Granted Apr 18, 2023·3 cites·14 claims
- 2683US11505554B2Substituted pyridines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2020·Granted Nov 22, 2022·1 cites·26 claims
- 2783US8063215B2Cyclopropyl amide derivativesARNOLD JAMES·Filed 2008·Granted Nov 22, 2011·7 cites·6 claims
- 2883US2025376475A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2025·Application pending·0 cites
- 2983US2025179112A1Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3082US7253173B24(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain of gastrointestinal disordersASTRAZENECA AB·Filed 2003·Granted Aug 7, 2007·15 cites·10 claims
- 3181US2025129066A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 3281US2025059213A1Lonp1 inhibitors, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3381US2025059214A1Amide-containing lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3480US6442714B1Web-based integrated testing and reporting systemCISCO TECHNOLOGY·Filed 1999·Granted Aug 27, 2002·129 cites·25 claims
- 3579US7618993B2CompoundsASTRAZENECA AB·Filed 2006·Granted Nov 17, 2009·4 cites·10 claims
- 3679US2025163068A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 3778US12145939B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2023·Granted Nov 19, 2024·0 cites·19 claims
- 3878US11866439B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2019·Granted Jan 9, 2024·1 cites·14 claims
- 3978US2025092084A1C7, c12, and c16 substituted neuroactive steroids and their methods of useSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4077US2023322790A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2023·Application pending·0 cites
- 4177US2024425481A1Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2024·Application pending·0 cites
- 4277US2025145629A1Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2024·Application pending·0 cites
- 4376US12030881B2Ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 9, 2024·0 cites·21 claims
- 4476US7226933B24-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disordersASTRAZENECA AB·Filed 2002·Granted Jun 5, 2007·9 cites·13 claims
- 4572US12344615B2Substituted pyridines as ion channel modulatorsPRAXIS PREC MEDICINES INC·Filed 2022·Granted Jul 1, 2025·0 cites·12 claims
- 4671US11993628B2C7, C12, and C16 substituted neuroactive steroids and their methods of useSAGE THERAPEUTICS INC·Filed 2021·Granted May 28, 2024·0 cites·39 claims
- 4771US7241764B24(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disordersASTRAZENECA AB·Filed 2003·Granted Jul 10, 2007·5 cites·17 claims
- 4870US2023219938A1Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2022·Application pending·0 cites
- 4969US11918571B2Compounds and their methods of usePRAXIS PREC MEDICINES INC·Filed 2022·Granted Mar 5, 2024·0 cites·19 claims
- 5069US10501459B2Substituted imidazo[1,2-a]pyridines as bromodomain inhibitorsNEOMED INST·Filed 2016·Granted Dec 10, 2019·1 cites·27 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrew Griffin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →